Is Murae Organisor overvalued or undervalued?

As of 14 August 2025, Murae Organisor's valuation grade has moved from risky to very attractive, indicating a significant improvement in its perceived value. The company is currently assessed as undervalued, with a PE ratio of 16.86, an EV to EBIT of 11.47, and a PEG ratio of 0.01, which suggests strong growth potential relative to its price. In comparison to its peers, Murae Organisor stands out with a much lower PE ratio than Sun Pharma (34.24) and Divi's Lab (70.57), both of which are classified as expensive. Additionally, while Murae's ROE is 13.47%, it is important to note that its ROCE is negative at -10.85%, indicating challenges in generating returns on capital. Despite recent poor stock performance, with a year-to-date decline of 70.05% compared to a 3.15% gain in the Sensex, the current valuation metrics suggest that Murae Organisor presents a compelling investment opportunity.